首页 › 基金 › APIS CAPITAL ADVISORS, LLC › TGTX

APIS CAPITAL ADVISORS, LLC 对 TGTX 的持仓历史

TG THERAPEUTICS INC · 医疗保健

APIS CAPITAL ADVISORS, LLC 在 Q3 2026 的 13F 申报中披露持有 TGTX(TG THERAPEUTICS INC)212,000 股,市值约 US$11.8M,约占其申报组合的 1.67%,在其申报持仓中市值排名第 20 位。 APIS CAPITAL ADVISORS, LLC 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)212.00K 股
申报持仓市值$11.83M
组合权重1.67%
首次申报Q3 2026
最近变动新进
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

APIS CAPITAL ADVISORS, LLC 对 TGTX 的持仓演变

APIS CAPITAL ADVISORS, LLC 于 Q3 2026 首次披露 TGTX 持仓:212,000 股(约 US$11.8M)。

逐季持仓明细

季度股数金额变化
Q3 2026 212.00K $11.83M 新进

关于 TGTX 与 13F 数据

TGTX(TG THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 TGTX,申报仓位最大的包括:Soleus Capital Management, L.P. (US$160.9M), CONGRESS ASSET MANAGEMENT CO (US$145.4M), Opaleye Management Inc. (US$29.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TGTX 的基金

查看 TGTX 的全部基金持有人 →

常见问题

How long has APIS CAPITAL ADVISORS, LLC held TGTX?

APIS CAPITAL ADVISORS, LLC has disclosed TGTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is APIS CAPITAL ADVISORS, LLC's current position in TGTX?

As of Q3 2026, APIS CAPITAL ADVISORS, LLC holds 212.00K shares of TGTX (TG THERAPEUTICS INC), valued at $11.83M, representing 1.67% of its reported portfolio and ranking #20.

Has APIS CAPITAL ADVISORS, LLC been buying or selling TGTX?

In the latest 13F filing (Q3 2026), APIS CAPITAL ADVISORS, LLC newly opened its position in TGTX.

Which other funds hold TGTX?

Other major institutional holders of TGTX include Soleus Capital Management, L.P., CONGRESS ASSET MANAGEMENT CO, Opaleye Management Inc., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.